New Enterprise Associates related stories
All articles and analysis
peHUB Wire: Wednesday, December 16, 2009Random Ramblings
- peHUB Wire: Wednesday, December 16, 2009
Random Ramblings
- Week in deals, Dec. 14, 2009
Summary of North American tech companies and other startups that raised venture financing in the past week
- peHUB Wire: Thursday, December 10, 2009
Random Ramblings
- peHUB Wire: Thursday, December 10, 2009
Random Ramblings
- Another Sign That VCs Are Getting More Active
We won’t officially know until early Q1 whether VC investment levels returned to normal in Q4, but I have yet another piece of anecdotal evidence that the market is improving. For the second month in a row, I’ve been surprised by the number of deals on Venture Capital Journal’s list of the Top 10 Most Active VCs. For most of this year, the top deal maker on the list has done about seven or eight deals per month. That changed in October, with New Enterprise Associates going into warp drive and closing 12 deals /55536/nea-goes-hyper-does-12-deals-in-october/ up from eight the prior month. For November, I found that not only did NEA do another dozen deals, but it wasn’t even at the top of the list. Intel Capital came in at No. 1 for November with 16 deals, up from just three deals the prior month. I’m not ready to say “Venture Is Back, Baby,” /57173/venture-is-back-baby/ like Jon Callaghan, but these data points at least give us reason to hope.
- peHUB Wire: Wednesday, December 9, 2009
Wednesday Warblings
- peHUB Wire: Wednesday, December 9, 2009
Wednesday Warblings
- Epizyme Expands Series B Round to $40 Million
Epizyme Inc., a Cambridge, Mass.-based biopharma company focused on the application of epigenetics, has raised $8 million in new Series B funding from Newe Enterprise Associates. This brings the round total to $40 million, including an earlier close led by Bay City Capital. The initial tranche also included Amgen Ventures, Astellas Venture Partners, MPM Capital and Kleiner Perkins Caufield and Byers. The company has now raised $54 million in total VC funding.